H1 Raises $40M for Its AI Healthcare Provider Directory

H1 has received $40 million in funding for its AI-enabled platform focused on healthcare provider directories and matching people with appropriate care. According to MobiHealthNews, the round was led by CVS Health Ventures, the investment arm of CVS Health, after H1 had recently collaborated with CVS Health on several projects.

This is not a story about an AI system promising to replace clinicians. The relevant layer is less theatrical and often more consequential: who the right provider is, where that provider fits, which case should be routed there, and how a health plan, health system or technology platform can make that decision without leaning on fragmented directories and manual searches.

H1 is a New York-based data company that offers an AI-enabled platform for identifying healthcare providers and helping people connect with appropriate care. The source description says the platform is meant to improve clinical workflows across technology companies, health plans, health systems and life sciences organizations. In practical terms, H1 is working on the infrastructure problem behind many digital health products: provider data, networks and clinical relevance are often not clean enough to support fast, reliable decisions at scale.

The role of CVS Health matters because the lead investor is not just a financial spectator. CVS Health Ventures sits inside a large healthcare organization, and H1’s recent collaboration with CVS Health gives the round more operational weight. For a company in this category, capital is useful, but access to real workflows, real constraints and large healthcare buyers can be just as important.

The central question for H1 is not whether an AI label can be attached to a provider directory. It can, and the market is already comfortable with that language. The harder question is whether the platform can consistently help organizations make better routing, partnership and workflow decisions. In healthcare, poor matching has a real cost: patients lose time, systems lose capacity, and providers receive cases that may not be the best fit.

That makes the funding notable without needing to inflate the claim. A $40 million round does not prove that H1 has solved provider matching, but it does signal where healthcare AI investment is moving: toward the less visible data layer that determines whether clinical workflows actually function. If healthcare AI is going to move from polished demos into routine operations, provider directories, network intelligence and workflow integration will matter as much as more attention-grabbing diagnostic models.